BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34347990)

  • 1. Rationalization of Mushroom-Based Preventive and Therapeutic Approaches to COVID-19: Review.
    Rahman MA; Rahman MS; Bashir NMB; Mia R; Hossain A; Saha SK; Kakon AJ; Sarker NC
    Int J Med Mushrooms; 2021; 23(5):1-11. PubMed ID: 34347990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Can Combat Cytokine Storm and Other COVID-19 Related Pathologies: A Review.
    Rowaiye AB; Ogugua AJ; Bur D; Wood T; Labbo Z; Chukwu C; Afolabi FJ; Nwonu EJ; Agbalalah T
    Int J Med Mushrooms; 2023; 25(5):1-15. PubMed ID: 37183915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID, Biologics, and Psoriasis Therapy.
    Elston DM
    J Am Acad Dermatol; 2020 Dec; 83(6):1577-1578. PubMed ID: 33051006
    [No Abstract]   [Full Text] [Related]  

  • 5. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments.
    Gurunathan S; Kang MH; Kim JH
    Front Immunol; 2021; 12():716407. PubMed ID: 34394121
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Khan FI; Hassan F; Lai D
    Front Immunol; 2021; 12():794780. PubMed ID: 35095870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Inflammation, Immunomodulation and Therapeutic Repair in Current Clinical Trials for the Management of COVID-19.
    Li C; Zhao H; Cheng L; Wang B
    Drug Des Devel Ther; 2021; 15():1345-1356. PubMed ID: 33824579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy.
    Molinelli E; Diotallevi F; Simonetti O; Brisigotti V; Sapigni C; Radi G; Campanati A; Offidani A
    Dermatol Ther; 2020 Nov; 33(6):e14256. PubMed ID: 32860474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targets of natural products for the management of cardiovascular symptoms of coronavirus disease 2019.
    Mohammadi Pour P; Farzaei MH; Soleiman Dehkordi E; Bishayee A; Asgary S
    Phytother Res; 2021 Oct; 35(10):5417-5426. PubMed ID: 34110678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multidisciplinary Approach to Coronavirus Disease (COVID-19).
    Gediz Erturk A; Sahin A; Bati Ay E; Pelit E; Bagdatli E; Kulu I; Gul M; Mesci S; Eryilmaz S; Oba Ilter S; Yildirim T
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
    Pinheiro MM; Fabbri A; Infante M
    Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
    Bilal M; Iqbal HMN
    Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19.
    Scarabel L; Guardascione M; Dal Bo M; Toffoli G
    Int J Infect Dis; 2021 Mar; 104():441-451. PubMed ID: 33476760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic plasma exchange therapy support for critical COVID-19: A case report.
    Hua T; Li M; Li X
    Ther Apher Dial; 2021 Aug; 25(4):533-535. PubMed ID: 32940386
    [No Abstract]   [Full Text] [Related]  

  • 16. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
    Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm.
    Peng X; Wang Y; Xi X; Jia Y; Tian J; Yu B; Tian J
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):231-247. PubMed ID: 33404925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19: Therapeutics and interventions currently under consideration.
    McFee RB
    Dis Mon; 2020 Sep; 66(9):101058. PubMed ID: 32868092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification, structure and mechanism of antiviral polysaccharides derived from edible and medicinal fungus.
    Guo Y; Chen X; Gong P
    Int J Biol Macromol; 2021 Jul; 183():1753-1773. PubMed ID: 34048833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.
    Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z
    Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.